أدوية ومنتجات صحية
Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Summary
| Type | Health product recall |
|---|---|
| Product | Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet |
| Issue | Health products - Packaging |
| What to do | Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns. |
| Distribution | National |
| Brand(s) | Lupin Pharma Canada Ltd. |
| Last updated | 2026-10-21 |
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Lupin Pharma Canada Ltd. |
Femyso Mifepristone 200 mg / Misoprostol 200 mcg tablet |
DIN 02560569 |
Kit, Tablet |
Mifepristone 200 mg / Misoprostol 200 mcg |
NR02557A-R |
Issue
Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
What you should do
- Verify whether your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Previous recalls or alerts
Background
Depth of recall: Retailers
Details
| Original published date | 2026-10-21 |
|---|---|
| Alert / recall type | Health product recall |
| Category | Health products - Drugs |
| Companies | Lupin Pharma Canada Limited. 550-1111 rue St-Charles Ouest Longueuil, QC, J4K 5G4 |
| Published by | Health Canada |
| Audience | General public Healthcare Industry |
| Distribution | National |
| Recall class | Type II |
| Identification number | RA-82831 |
Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/femyso-affected-lot-may-contain-two-green-mifepristone-cartons-or-two-pink-0